RIO DE JANEIRO, BRAZIL - Brazil's national health regulator (ANVISA) announced that on Tuesday June 29 it received the request for emergency use of the vaccine Covaxin, of experimental character, sent by the company Precisa Medicamentos, which represents in Brazil the Indian pharmaceutical company Bharat Biotech.
The company had announced yesterday that it would apply, saying that the approval is "the last remaining step for the 20 million doses negotiated with the Ministry of Health to be introduced and used in Brazil."
The pharmaceutical company's decision comes amid controversy over the contract signed by the Ministry of Health with . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here